Saturday 27 August 2011

Tamsunax




Tamsunax may be available in the countries listed below.


Ingredient matches for Tamsunax



Tamsulosin

Tamsulosin hydrochloride (a derivative of Tamsulosin) is reported as an ingredient of Tamsunax in the following countries:


  • Switzerland

International Drug Name Search

Wednesday 24 August 2011

Crotamiton




In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0000483-63-6

Chemical Formula

C13-H17-N-O

Molecular Weight

203

Therapeutic Category

Scabicide

Chemical Name

2-Butenamide, N-ethyl-N-(2-methylphenyl)-

Foreign Names

  • Crotamitonum (Latin)
  • Crotamiton (German)
  • Crotamiton (French)
  • Crotamiton (Spanish)

Generic Names

  • Crotamiton (OS: BAN, JAN, DCF)
  • Crotamitone (OS: DCIT)
  • G 7857 (IS)
  • Crotamiton (PH: BP 2010, USP 32, Ph. Eur. 6)
  • Crotamitonum (PH: Ph. Eur. 6)

Brand Names

  • Acomexol
    Armstrong, Mexico


  • Crodex
    Gaco, Bangladesh


  • Cromiton
    Ambalal Sarabhai Enterprises, Ethiopia


  • Crotamitex
    Gepepharm, Germany


  • Crotamiton Genfar
    Genfar, Colombia


  • Crotamiton
    Farmapol, Poland; Genfar, Peru; Trepon Werck, Ethiopia


  • Crotan
    Owen, United States


  • Crotanol
    Roemmers, Venezuela


  • Crotorax
    Sarabhai, Bahrain; Sarabhai, India


  • Curex
    Kumudini, Bangladesh


  • Eraxil
    Gepepharm, Germany


  • Eurax
    Medis, Slovenia; Medis Adria, Croatia (Hrvatska); Novartis, United Arab Emirates; Novartis, Bahrain; Novartis, Chile; Novartis, Colombia; Novartis, Ethiopia; Novartis, Ghana; Novartis, Guyana; Novartis, Hong Kong; Novartis, Israel; Novartis, Iraq; Novartis, Jordan; Novartis, Japan; Novartis, Kenya; Novartis, Kuwait; Novartis, Lebanon; Novartis, Sri Lanka; Novartis, Luxembourg; Novartis, Libya; Novartis, Malta; Novartis, Mexico; Novartis, Malaysia; Novartis, Nigeria; Novartis, Norway; Novartis, Oman; Novartis, Philippines; Novartis, Portugal; Novartis, Qatar; Novartis, Saudi Arabia; Novartis, Sudan; Novartis, Tunisia; Novartis, Tanzania; Novartis, Yemen; Novartis, Zimbabwe; Novartis Consumer Health, Austria; Novartis Consumer Health, Australia; Novartis Consumer Health, Belgium; Novartis Consumer Health, Switzerland; Novartis Consumer Health, Egypt; Novartis Consumer Health, United Kingdom; Novartis Consumer Health, Ireland; Novartis Consumer Health, Italy; Novartis Consumer Health, New Zealand; Novartis Consumer Health, Peru; Novartis Consumer Health, Vietnam; Novartis Consumer Health, South Africa; Novartis OTC, Singapore; Novartis Santé Familiale, France; Ranbaxy, United States


  • Eurax H (Crotamiton and Hydrocortisone)
    Novartis, Japan


  • Eurax-hydrocortisone (Crotamiton and Hydrocortisone)
    Novartis Consumer Health, United Kingdom


  • Lominian
    Towa Yakuhin, Japan


  • Marax
    Marching Pharmaceutical, Hong Kong


  • Moz-Bite
    Hoe, Singapore; Hoe Pharmaceuticals, Ethiopia


  • Otostan (veterinary use)
    Véto-Centre, France


  • Pielic
    Licol, Colombia


  • Prurex
    Opalia, Tunisia


  • Scabicin
    Cosmofarma, Portugal; Fischer, Israel


  • Ulex
    Sinphar, Taiwan


  • Vaselastic
    Novamed, Colombia


  • Veteusan (veterinary use)
    Richter, Austria

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Propranolol AL




Propranolol AL may be available in the countries listed below.


Ingredient matches for Propranolol AL



Propranolol

Propranolol hydrochloride (a derivative of Propranolol) is reported as an ingredient of Propranolol AL in the following countries:


  • Germany

International Drug Name Search

Saturday 20 August 2011

Adracon




Adracon may be available in the countries listed below.


Ingredient matches for Adracon



Sumatriptan

Sumatriptan is reported as an ingredient of Adracon in the following countries:


  • Peru

International Drug Name Search

Medocephine




Medocephine may be available in the countries listed below.


Ingredient matches for Medocephine



Ceftriaxone

Ceftriaxone is reported as an ingredient of Medocephine in the following countries:


  • Vietnam

International Drug Name Search

Thursday 18 August 2011

Keppra


See also: Generic Keppra XR


Keppra is a brand name of levetiracetam, approved by the FDA in the following formulation(s):


KEPPRA (levetiracetam - injectable; iv (infusion))



  • Manufacturer: UCB INC

    Approval date: July 31, 2006

    Strength(s): 500MG/5ML (100MG/ML) [RLD][AP]

KEPPRA (levetiracetam - solution; oral)



  • Manufacturer: UCB INC

    Approval date: July 15, 2003

    Strength(s): 100MG/ML [RLD][AA]

KEPPRA (levetiracetam - tablet; oral)



  • Manufacturer: UCB INC

    Approval date: November 30, 1999

    Strength(s): 250MG [AB], 500MG [AB], 750MG [AB]


  • Manufacturer: UCB INC

    Approval date: January 6, 2006

    Strength(s): 1GM [RLD][AB]

Has a generic version of Keppra been approved?


A generic version of Keppra has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Keppra and have been approved by the FDA:


levetiracetam injectable; iv (infusion)



  • Manufacturer: INNOPHARMA LLC

    Approval date: August 5, 2011

    Strength(s): 500MG/5ML (100MG/ML) [AP]


  • Manufacturer: NEXUS PHARMS

    Approval date: May 26, 2010

    Strength(s): 500MG/5ML (100MG/ML) [AP]


  • Manufacturer: PHARMAFORCE

    Approval date: January 31, 2012

    Strength(s): 500MG/5ML (100MG/ML) [AP]


  • Manufacturer: SUN PHARM INDS LTD

    Approval date: June 16, 2010

    Strength(s): 500MG/5ML (100MG/ML) [AP]

levetiracetam solution; oral



  • Manufacturer: ACTAVIS MID ATLANTIC

    Approval date: January 15, 2009

    Strength(s): 100MG/ML [AA]


  • Manufacturer: AMNEAL PHARMS

    Approval date: October 27, 2009

    Strength(s): 100MG/ML [AA]


  • Manufacturer: APOTEX

    Approval date: August 5, 2011

    Strength(s): 100MG/ML [AA]


  • Manufacturer: AUROBINDO PHARM

    Approval date: January 15, 2009

    Strength(s): 100MG/ML [AA]


  • Manufacturer: CYPRESS PHARM

    Approval date: January 16, 2009

    Strength(s): 100MG/ML [AA]


  • Manufacturer: LUPIN LTD

    Approval date: October 17, 2011

    Strength(s): 100MG/ML [AA]


  • Manufacturer: ROXANE

    Approval date: January 15, 2009

    Strength(s): 100MG/ML [AA]


  • Manufacturer: SILARX

    Approval date: April 3, 2009

    Strength(s): 100MG/ML [AA]


  • Manufacturer: TARO

    Approval date: February 10, 2009

    Strength(s): 100MG/ML [AA]


  • Manufacturer: TOLMAR

    Approval date: January 15, 2009

    Strength(s): 100MG/ML [AA]


  • Manufacturer: TRIS PHARMA INC

    Approval date: September 30, 2010

    Strength(s): 100MG/ML [AA]


  • Manufacturer: WOCKHARDT

    Approval date: March 3, 2010

    Strength(s): 100MG/ML [AA]

levetiracetam tablet; oral



  • Manufacturer: ACCORD HLTHCARE

    Approval date: February 14, 2011

    Strength(s): 1GM [AB], 250MG [AB], 500MG [AB], 750MG [AB]


  • Manufacturer: AJANTA PHARMA

    Approval date: June 14, 2011

    Strength(s): 1GM [AB], 250MG [AB], 500MG [AB], 750MG [AB]


  • Manufacturer: APOTEX INC

    Approval date: March 13, 2009

    Strength(s): 1GM [AB], 250MG [AB], 500MG [AB], 750MG [AB]


  • Manufacturer: AUROBINDO PHARMA

    Approval date: January 15, 2009

    Strength(s): 1GM [AB], 250MG [AB], 500MG [AB], 750MG [AB]


  • Manufacturer: BIOKEY

    Approval date: November 5, 2010

    Strength(s): 500MG [AB]


  • Manufacturer: BOCA PHARMA

    Approval date: March 20, 2009

    Strength(s): 250MG [AB], 500MG [AB], 750MG [AB]


  • Manufacturer: BRECKENRIDGE PHARM

    Approval date: August 18, 2011

    Strength(s): 1GM [AB], 250MG [AB], 500MG [AB], 750MG [AB]


  • Manufacturer: COBALT LABS INC

    Approval date: January 15, 2009

    Strength(s): 250MG [AB], 500MG [AB], 750MG [AB]


  • Manufacturer: DR REDDYS LABS LTD

    Approval date: January 15, 2009

    Strength(s): 1GM [AB], 250MG [AB], 500MG [AB], 750MG [AB]


  • Manufacturer: HETERO DRUGS LTD

    Approval date: October 8, 2010

    Strength(s): 1GM [AB], 250MG [AB], 500MG [AB], 750MG [AB]


  • Manufacturer: INVAGEN PHARMS

    Approval date: January 15, 2009

    Strength(s): 250MG [AB], 500MG [AB], 750MG [AB]


  • Manufacturer: LUPIN

    Approval date: January 15, 2009

    Strength(s): 1GM [AB], 250MG [AB], 500MG [AB], 750MG [AB]


  • Manufacturer: METHAPHARM

    Approval date: July 28, 2010

    Strength(s): 1GM [AB], 250MG [AB], 500MG [AB], 750MG [AB]


  • Manufacturer: MYLAN

    Approval date: November 4, 2008

    Strength(s): 250MG [AB], 500MG [AB], 750MG [AB]


  • Manufacturer: MYLAN

    Approval date: December 8, 2009

    Strength(s): 1GM [AB]


  • Manufacturer: ORCHID HLTHCARE

    Approval date: January 15, 2009

    Strength(s): 250MG [AB], 500MG [AB], 750MG [AB]


  • Manufacturer: ORCHID HLTHCARE

    Approval date: August 5, 2010

    Strength(s): 1GM [AB]


  • Manufacturer: ROXANE

    Approval date: January 15, 2009

    Strength(s): 1GM [AB], 250MG [AB], 500MG [AB], 750MG [AB]


  • Manufacturer: SANDOZ

    Approval date: January 15, 2009

    Strength(s): 1GM [AB], 250MG [AB], 500MG [AB], 750MG [AB]


  • Manufacturer: SOLCO HLTHCARE

    Approval date: February 10, 2009

    Strength(s): 1GM [AB], 250MG [AB], 500MG [AB], 750MG [AB]


  • Manufacturer: TARO

    Approval date: February 1, 2010

    Strength(s): 1GM [AB], 250MG [AB], 500MG [AB], 750MG [AB]


  • Manufacturer: TEVA PHARMS

    Approval date: January 15, 2009

    Strength(s): 1GM [AB], 250MG [AB], 500MG [AB], 750MG [AB]


  • Manufacturer: TORRENT PHARMS

    Approval date: January 15, 2009

    Strength(s): 1GM [AB], 250MG [AB], 500MG [AB], 750MG [AB]


  • Manufacturer: VINTAGE PHARMS

    Approval date: December 14, 2010

    Strength(s): 1GM [AB], 250MG [AB], 500MG [AB], 750MG [AB]


  • Manufacturer: WATSON LABS

    Approval date: January 15, 2009

    Strength(s): 1GM [AB]


  • Manufacturer: WOCKHARDT

    Approval date: January 15, 2009

    Strength(s): 1GM [AB], 250MG [AB], 500MG [AB], 750MG [AB]


  • Manufacturer: ZYDUS PHARMS USA INC

    Approval date: April 29, 2009

    Strength(s): 1GM [AB], 250MG [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Keppra. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Keppra.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • September 19, 2010 - PEDIATRIC EXCLUSIVITY

See also...

  • Keppra Consumer Information (Drugs.com)
  • Keppra Consumer Information (Wolters Kluwer)
  • Keppra Solution Consumer Information (Wolters Kluwer)
  • Keppra Tablets Consumer Information (Wolters Kluwer)
  • Keppra Consumer Information (Cerner Multum)
  • Keppra Advanced Consumer Information (Micromedex)
  • Keppra Intravenous Advanced Consumer Information (Micromedex)
  • Keppra AHFS DI Monographs (ASHP)
  • Levetiracetam Consumer Information (Wolters Kluwer)
  • Levetiracetam Extended-Release Tablets Consumer Information (Wolters Kluwer)
  • Levetiracetam Solution Consumer Information (Wolters Kluwer)
  • Levetiracetam Tablets Consumer Information (Wolters Kluwer)
  • Levetiracetam Consumer Information (Cerner Multum)
  • Levetiracetam Advanced Consumer Information (Micromedex)
  • Levetiracetam Intravenous Advanced Consumer Information (Micromedex)
  • Levetiracetam AHFS DI Monographs (ASHP)

Tuesday 16 August 2011

Hexit




Hexit may be available in the countries listed below.


Ingredient matches for Hexit



Lindane

Lindane is reported as an ingredient of Hexit in the following countries:


  • Canada

International Drug Name Search

Friday 12 August 2011

Oftensin




Oftensin may be available in the countries listed below.


Ingredient matches for Oftensin



Timolol

Timolol maleate (a derivative of Timolol) is reported as an ingredient of Oftensin in the following countries:


  • Czech Republic

  • Poland

International Drug Name Search

Tuesday 9 August 2011

Cimagen




Cimagen may be available in the countries listed below.


Ingredient matches for Cimagen



Cimetidine

Cimetidine is reported as an ingredient of Cimagen in the following countries:


  • Ireland

International Drug Name Search

Sunday 7 August 2011

Lorafem




Lorafem may be available in the countries listed below.


Ingredient matches for Lorafem



Loracarbef

Loracarbef monohydrate (a derivative of Loracarbef) is reported as an ingredient of Lorafem in the following countries:


  • Germany

International Drug Name Search

Phenytek




In the US, Phenytek (phenytoin systemic) is a member of the following drug classes: group I antiarrhythmics, hydantoin anticonvulsants and is used to treat Anxiety, Arrhythmia, Epilepsy, Peripheral Neuropathy, Seizures, Status Epilepticus and Trigeminal Neuralgia.

US matches:

  • Phenytek Extended-Release Capsules

  • Phenytek

Ingredient matches for Phenytek



Phenytoin

Phenytoin sodium salt (a derivative of Phenytoin) is reported as an ingredient of Phenytek in the following countries:


  • United States

International Drug Name Search

Wednesday 3 August 2011

Midazolam DeltaSelect




Midazolam DeltaSelect may be available in the countries listed below.


Ingredient matches for Midazolam DeltaSelect



Midazolam

Midazolam hydrochloride (a derivative of Midazolam) is reported as an ingredient of Midazolam DeltaSelect in the following countries:


  • Austria

  • Germany

  • Netherlands

International Drug Name Search

Palovir




Palovir may be available in the countries listed below.


Ingredient matches for Palovir



Acyclovir

Aciclovir is reported as an ingredient of Palovir in the following countries:


  • Indonesia

International Drug Name Search

Tuesday 2 August 2011

Acetaminofén Genfar




Acetaminofén Genfar may be available in the countries listed below.


Ingredient matches for Acetaminofén Genfar



Paracetamol

Paracetamol is reported as an ingredient of Acetaminofén Genfar in the following countries:


  • Colombia

  • Ecuador

International Drug Name Search